Pivotal Study of the CapsoCam Colon (CV-3) in Detecting Colonic Polyps, Using Colonoscopy as the Reference

Completed · Not applicable

Conditions studied: Colonic Polyp

In brief

This study will evaluate the safety and effectiveness of the CapsoCam Colon (CV-3) endoscope system for the detection of colonic polyps.

Key facts

Study ID

NCT04607746

Run by

Capso Vision, Inc.

People needed

1337

Starts

2021-01-06

Expected to finish

2025-02-14

Last updated by the study team

2025-07-08

Who can join

Age: 45 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 45-75 years of age
• Committed to undergo a colonoscopy, independent of this study
• Choose to participate and must have signed the IRB-approved informed consent document and agreed to release colonoscopy images and results report to Sponsor

You may not qualify if…

• Colonoscopy or CT-colonography within the past 5 years that demonstrated no polyps
• Has contraindication for capsule endoscopy or colonoscopy
• Subject is suspected or diagnosed with familial adenomatous polyposis, hereditary non polyposis colon cancer, or any high-risk genetic syndrome
• Subject is suspected or diagnosed with inflammatory bowel disease such as ulcerative colitis or Crohn's disease
• History of incomplete colonoscopy
• Type I or uncontrolled II Diabetes (Uncontrolled defined as HbA1C>6.4 within the past 3 months and/or with history of constipation or gastroparesis.)
• Impaired cardiac function assessed as greater than NYHA Class II
• History of small- or large-bowel obstructive condition
• Known history of swallowing disorder, and/or ischemic bowel disease neuropathies and/or radiation enteritis
• Known history of NSAID enteropathy and stricture resulting from taking NSAIDs on a regular basis that, in the opinion of the Investigator, would put the subject at greater risk for capsule endoscope retention
• Known allergy to ingredients used in bowel preparation and boosters
• Daily and/or regular narcotic use
• Decompensated cirrhosis
• Prior abdominal radiation therapy
• Diagnosis of anorexia or bulimia
• History of or suspicion of any of the following: strictures, volvulus or intestinal obstruction, or internal hernias or abdominal surgeries that the Investigator believes should exclude the patient from study participation
• Known or suspected megacolon
• Scheduled to undergo MRI examination within 7 days after ingestion of the capsule
• Has known slow gastric-emptying time or confirmed diagnosis of gastroparesis
• Pregnant or nursing or is of child-bearing potential and does not practice medically acceptable methods of contraception. WOCBP must have a negative urine pregnancy test at screening.
• Unable to follow or tolerate fasting, bowel preparation, and other study procedures
• Any documented medical or psychological condition or significant concurrent illness which, in the Investigator's opinion, would make it unsafe for the subject to participate in this research study or would affect the validity of the study results
• Are currently enrolled in an interventional clinical study or currently enrolled in or within the last 30 days, a pharmaceutical clinical study
• Chronic constipation as defined by <3 bowel movements per week, or the use of routine laxatives (other than fiber) to attain regular bowel movements

Where it is running

• Mayo Clinic — Scottsdale, Arizona, United States
• Gastro Care Institute — Lancaster, California, United States
• inSite Digestive Health Care — Los Gatos, California, United States
• Knowledge Research Center — Orange, California, United States
• Kaiser Permanente Northern California — San Leandro, California, United States
• Advanced Research Institute — New Port Richey, Florida, United States
• Digestive and Liver Center of Florida — Orlando, Florida, United States
• Advanced Gastroenterology Associates, LLC — Palm Harbor, Florida, United States
• Advanced Research Institute — St. Petersburg, Florida, United States
• Digestive Health Services — Downers Grove, Illinois, United States
• Northshore Center for Gastroenterology — Libertyville, Illinois, United States
• Suburban Gastroenterology — Naperville, Illinois, United States
• Southwest Gastroenterology — New Lenox, Illinois, United States
• Digestive Health Specialists — Chelmsford, Massachusetts, United States
• West Michigan Clinical Research Center — Wyoming, Michigan, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Hattiesburg GI Associates — Hattiesburg, Mississippi, United States
• NY total Medical Care, PC — Brooklyn, New York, United States
• Gastroenterology Group of Rochester — Rochester, New York, United States
• Great Lakes Gastroenterology Research — Mentor, Ohio, United States
• Tri-Cities Gastroenterology — Kingsport, Tennessee, United States
• Vilo Research Group — Houston, Texas, United States
• Gastroenterology Consultants of SW Virginia — Roanoke, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.